Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

The CAR-NK cell product studied in this trial ... These therapeutic CAR-NK cells are made from induced pluripotent stem cells derived from healthy donor fibroblast cell lines with centralized ...

NK cell therapies can be made more quickly and at lower cost ... NK cells for potential therapies from induced pluripotent stem (iPS) cells — skin or blood cells that have been reprogrammed ...

Century Therapeutics’ deliberate, high-caliber approach to generating induced pluripotent stem cell-derived products ... comprises 10 iPSC-derived T or NK cell products that have shown potent ...

A team of Japanese researchers has changed epithelial cells from the livers and stomachs of adult mice into pluripotent cells that resemble embryonic stem cells ...

Researchers have for the first time been able to generate a pluripotent stem cell line from the cells of a patient with a genetic disease, according to a study appearing tomorrow (August 1) in Science ...

Cellistic, a pioneer in induced pluripotent stem cells (iPSC)-based cell therapies ... and feeder-free process for the scale-up and differentiation of iPSC cells into natural killer cells. All key ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

The Stem Cell Core provides access to a streamlined, IRB-approved consenting process for acquisition of patient samples and generation of pluripotent stem cells and stem cell-derivatives for basic and ...